Expression of multiple forms of 3'-end variant CCK2 receptor mRNAs in human pancreatic adenocarcinomas
2011

Expression of CCK2 Receptor mRNAs in Pancreatic Cancer

Sample size: 17 publication Evidence: moderate

Author Information

Author(s): Anna Ryberg, Kurt Borch, Hans-Jürg Monstein

Primary Institution: Linköping University

Hypothesis

The co-expression of CCK2R and gastrin mRNA plays a pivotal role in the progression of pancreatic cancer.

Conclusion

CCK2R and multiple CCK2i4svR-like mRNAs are expressed in human pancreatic adenocarcinoma, but the originally described CCK2i4svR mRNA is rarely expressed.

Supporting Evidence

  • CCK2R mRNA was expressed in 12 of 17 biopsy specimens.
  • CCK2i4svR mRNA was expressed in only one of the biopsy specimens.
  • Co-expression of CCK2R and gastrin mRNA occurred in 10 of 17 biopsy specimens.

Takeaway

Scientists studied how certain receptors are expressed in pancreatic cancer and found that while some are common, one specific type is very rare.

Methodology

PCR amplification and DNA sequencing were used to analyze mRNA expression in biopsy specimens.

Limitations

The study only analyzed a limited number of biopsy specimens and may not represent all pancreatic adenocarcinomas.

Participant Demographics

Anonymous archival pancreatic tumor tissue samples from 17 deceased patients.

Digital Object Identifier (DOI)

10.1186/1756-0500-4-131

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication